RxDoctor Payments Data

Nicholas Lukacs, DO

Otolaryngology/Facial Plastic Surgery · Fort Mill, SCNPI 1790804813

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 35 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 12 manufacturers, the largest accounting for just 19.9% — the pattern of someone who eats at a lot of different presentations.

$1,407in general payments, 2019–2025

Across 35 payments — averaging $40.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$280
  • Aerin Medical Inc.$234
  • Intersect ENT, Inc.$192
  • Xoran Technologies LLC$150
  • Regeneron Healthcare Solutions, Inc.$114
  • AstraZeneca$112
  • plus $325 from 6 others

What the payments were for

  • Food & beverage$1,407100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few otolaryngology/facial plastic surgery providers in South Carolinato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$81,937
Medicare patients
241
Services billed
875

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Olopatadine Hcl21$3,389
Pantoprazole Sodium191$1,454
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth13$1,352
Mometasone Furoate17$1,096
Ofloxacin45$1,090
Azelastine Hcl37$1,032
Ipratropium Bromide39$919
Esomeprazole Magnesium16$719
Fluocinolone Acetonide Oil15$688
Fluticasone Propionate28$527
Famotidine32$516
Cefdinir14$496
Omeprazole20$373
Prednisone29$328
Doxycycline Hyclate17$283

Paid to pharmacies, not to this prescriber.

Other otolaryngology/facial plastic surgery in Fort Mill

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →